Vol. 6, Issue 8 (2017)

Methods: This prospective study was carried out at Department of Ophthalmology, Sambhram Institute of Medical Sciences and Research, Kolar, Karnataka, India over a period from April 2016 to March 2017, during which 94 eyes were examined. Following treatment, visual function was assessed.

Results: Seventy-four percent of the eyes had a reduction in median log MAR visual acuity from 1.49 at baseline to 0.8 at the one-month follow-up. Additionally, statistically significant improvements were observed in color vision, central fields, brightness sensitivity, and red desaturation. The average age was 40.0 years, and 55.6% of the participants were.

Conclusion: After treatment, there was a noticeable improvement in visual function. Concomitant demyelination was observed in our investigation in relation to this study.